ID   KHDR1_RAT               Reviewed;         443 AA.
AC   Q91V33;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   29-MAY-2024, entry version 160.
DE   RecName: Full=KH domain-containing, RNA-binding, signal transduction-associated protein 1;
DE   AltName: Full=GAP-associated tyrosine phosphoprotein p62;
DE   AltName: Full=Src-associated in mitosis 68 kDa protein;
DE            Short=Sam68;
DE   AltName: Full=p21 Ras GTPase-activating protein-associated p62;
DE   AltName: Full=p68;
GN   Name=Khdrbs1 {ECO:0000312|RGD:621459};
GN   Synonyms=Sam68 {ECO:0000312|EMBL:AAH61987.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAL09361.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], HOMOOLIGOMERIZATION, AND INTERACTION WITH
RP   KHDRB2.
RX   PubMed=15345239; DOI=10.1016/j.mcn.2004.04.011;
RA   Stoss O., Novoyatleva T., Gencheva M., Olbrich M., Benderska N., Stamm S.;
RT   "p59(fyn)-mediated phosphorylation regulates the activity of the tissue-
RT   specific splicing factor rSLM-1.";
RL   Mol. Cell. Neurosci. 27:8-21(2004).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAK77001.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley {ECO:0000312|EMBL:AAK77001.1};
RA   Wang J.-M., Tseng C.-N., Yao Y., Wang Z.-Z.;
RT   "Characterization of Sam68 in skeletal muscle and brain of rat.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000312|EMBL:AAH61987.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate {ECO:0000312|EMBL:AAH61987.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   FUNCTION, PHOSPHORYLATION, AND INTERACTION WITH PIK3R1.
RX   PubMed=10437794; DOI=10.1016/s0014-5793(99)00887-x;
RA   Sanchez-Margalet V., Najib S.;
RT   "p68 Sam is a substrate of the insulin receptor and associates with the SH2
RT   domains of p85 PI3K.";
RL   FEBS Lett. 455:307-310(1999).
RN   [5] {ECO:0000305}
RP   INTERACTION WITH FNBP4; WBP4; FYN AND PLCG1, AND METHYLATION.
RX   PubMed=10748127; DOI=10.1074/jbc.m909368199;
RA   Bedford M.T., Frankel A., Yaffe M.B., Clarke S., Leder P., Richard S.;
RT   "Arginine methylation inhibits the binding of proline-rich ligands to Src
RT   homology 3, but not WW, domains.";
RL   J. Biol. Chem. 275:16030-16036(2000).
CC   -!- FUNCTION: Recruited and tyrosine phosphorylated by several receptor
CC       systems, for example the T-cell, leptin and insulin receptors. Once
CC       phosphorylated, functions as an adapter protein in signal transduction
CC       cascades by binding to SH2 and SH3 domain-containing proteins. Role in
CC       G2-M progression in the cell cycle. Represses CBP-dependent
CC       transcriptional activation apparently by competing with other nuclear
CC       factors for binding to CBP. Also acts as a putative regulator of mRNA
CC       stability and/or translation rates and mediates mRNA nuclear export.
CC       Positively regulates the association of constitutive transport element
CC       (CTE)-containing mRNA with large polyribosomes and translation
CC       initiation. May not be involved in the nucleocytoplasmic export of
CC       unspliced (CTE)-containing RNA species. RNA-binding protein that plays
CC       a role in the regulation of alternative splicing and influences mRNA
CC       splice site selection and exon inclusion. Binds to RNA containing 5'-
CC       [AU]UAA-3' as a bipartite motif spaced by more than 15 nucleotides.
CC       Binds poly(A). Can regulate CD44 alternative splicing in a Ras pathway-
CC       dependent manner. In cooperation with HNRNPA1 modulates alternative
CC       splicing of BCL2L1 by promoting splicing toward isoform Bcl-X(S), and
CC       of SMN1. Can regulate alternative splicing of NRXN1 and NRXN3 in the
CC       laminin G-like domain 6 containing the evolutionary conserved neurexin
CC       alternative spliced segment 4 (AS4) involved in neurexin selective
CC       targeting to postsynaptic partners. In a neuronal activity-dependent
CC       manner cooperates synergistically with KHDRBS2/SLIM-1 in regulation of
CC       NRXN1 exon skipping at AS4. The cooperation with KHDRBS2/SLIM-1 is
CC       antagonistic for regulation of NXRN3 alternative splicing at AS4 (By
CC       similarity). {ECO:0000250|UniProtKB:Q07666,
CC       ECO:0000250|UniProtKB:Q60749, ECO:0000269|PubMed:10437794}.
CC   -!- SUBUNIT: Self-associates to form homooligomers when bound to RNA,
CC       oligomerization appears to be limited when binding to proteins.
CC       Interacts with KHDRBS3/SLIM-2 (By similarity). Interacts with
CC       KHDRBS2/SLIM-1; heterooligomer formation of KHDRBS family proteins may
CC       modulate RNA substrate specificity (PubMed:15345239). Interacts with
CC       PIK3R1, PLCG1 (PubMed:10437794, PubMed:10748127). Interacts with RASA1,
CC       GRB2, SRC, RBMY1A1, CBP, PRMT1, APC, HNRNPA1. Interacts with PTK6 (via
CC       SH3 and SH2 domains). Forms a complex with ILF2, ILF3, YLPM1, RBMX,
CC       NCOA5 and PPP1CA (By similarity). Binds WBP4/FBP21 (via WW domains),
CC       FNBP4/FBP30 (via WW domains). Interacts (via Arg/Gly-rich-flanked Pro-
CC       rich regions) with FYN (via the SH3 domain) (PubMed:10748127).
CC       Interacts with the non-receptor tyrosine kinase SRMS; the interaction
CC       leads to phosphorylation of KHDRBS1 (By similarity). Interacts with
CC       ZBTB7A; negatively regulates KHDRBS1 splicing activity toward BCL2L1
CC       (By similarity). {ECO:0000250|UniProtKB:Q07666,
CC       ECO:0000250|UniProtKB:Q60749, ECO:0000269|PubMed:10437794,
CC       ECO:0000269|PubMed:10748127, ECO:0000269|PubMed:15345239}.
CC   -!- INTERACTION:
CC       Q91V33; Q63787: Pik3r1; NbExp=2; IntAct=EBI-518436, EBI-518443;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q07666}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q07666}. Membrane
CC       {ECO:0000250|UniProtKB:Q07666}. Note=Predominantly located in the
CC       nucleus but also located partially in the cytoplasm.
CC       {ECO:0000250|UniProtKB:Q07666}.
CC   -!- DOMAIN: The KH domain is required for binding to RNA.
CC       {ECO:0000269|PubMed:15345239}.
CC   -!- DOMAIN: The Pro-rich domains are flanked by Arg/Gly-rich motifs which
CC       can be asymmetric dimethylated on arginine residues to give the
CC       DMA/Gly-rich regions. Selective methylation on these motifs can
CC       modulate protein-protein interactions.
CC   -!- PTM: Tyrosine phosphorylated by several non-receptor tyrosine kinases
CC       including LCK, FYN and JAK3. Also tyrosine phosphorylated by the non-
CC       receptor tyrosine kinase SRMS in an EGF-dependent manner.
CC       Phosphorylation by PTK6 negatively regulates its RNA binding ability.
CC       Phosphorylation by PTK6 at Tyr-440 dictates the nuclear localization of
CC       KHDRBS1. {ECO:0000250|UniProtKB:Q07666}.
CC   -!- PTM: Acetylated. Positively correlates with ability to bind RNA (By
CC       similarity). {ECO:0000250|UniProtKB:Q07666}.
CC   -!- PTM: Arginine methylation is required for nuclear localization,
CC       Inhibits interaction with Src-like SH3 domains, but not interaction
CC       with WW domains of WBP4/FBP21 and FNBP4/FBP30.
CC       {ECO:0000250|UniProtKB:Q07666}.
CC   -!- SIMILARITY: Belongs to the KHDRBS family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF305619; AAL09361.1; -; mRNA.
DR   EMBL; AF393783; AAK77001.1; -; mRNA.
DR   EMBL; BC061987; AAH61987.1; -; mRNA.
DR   RefSeq; NP_569089.1; NM_130405.1.
DR   AlphaFoldDB; Q91V33; -.
DR   SMR; Q91V33; -.
DR   BioGRID; 250715; 4.
DR   CORUM; Q91V33; -.
DR   IntAct; Q91V33; 2.
DR   STRING; 10116.ENSRNOP00000066894; -.
DR   iPTMnet; Q91V33; -.
DR   PhosphoSitePlus; Q91V33; -.
DR   SwissPalm; Q91V33; -.
DR   jPOST; Q91V33; -.
DR   PaxDb; 10116-ENSRNOP00000066894; -.
DR   Ensembl; ENSRNOT00000075270.2; ENSRNOP00000066894.1; ENSRNOG00000046794.2.
DR   Ensembl; ENSRNOT00055048583; ENSRNOP00055039938; ENSRNOG00055028072.
DR   Ensembl; ENSRNOT00060042435; ENSRNOP00060035158; ENSRNOG00060024486.
DR   Ensembl; ENSRNOT00065042864; ENSRNOP00065035080; ENSRNOG00065024942.
DR   GeneID; 117268; -.
DR   KEGG; rno:117268; -.
DR   AGR; RGD:621459; -.
DR   CTD; 10657; -.
DR   RGD; 621459; Khdrbs1.
DR   eggNOG; KOG1588; Eukaryota.
DR   GeneTree; ENSGT00940000155718; -.
DR   HOGENOM; CLU_034976_0_0_1; -.
DR   InParanoid; Q91V33; -.
DR   OMA; GYDENYT; -.
DR   OrthoDB; 1397at2759; -.
DR   PhylomeDB; Q91V33; -.
DR   Reactome; R-RNO-8849468; PTK6 Regulates Proteins Involved in RNA Processing.
DR   PRO; PR:Q91V33; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000046794; Expressed in thymus and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0070618; C:Grb2-Sos complex; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0008143; F:poly(A) binding; ISO:RGD.
DR   GO; GO:0008266; F:poly(U) RNA binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0003723; F:RNA binding; ISS:UniProtKB.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:RGD.
DR   GO; GO:0017124; F:SH3 domain binding; IDA:RGD.
DR   GO; GO:0035591; F:signaling adaptor activity; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0046833; P:positive regulation of RNA export from nucleus; ISS:UniProtKB.
DR   GO; GO:0045948; P:positive regulation of translational initiation; ISS:UniProtKB.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0048024; P:regulation of mRNA splicing, via spliceosome; ISO:RGD.
DR   GO; GO:0046831; P:regulation of RNA export from nucleus; ISS:UniProtKB.
DR   GO; GO:0009966; P:regulation of signal transduction; NAS:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISO:RGD.
DR   CDD; cd22468; KH-I_KHDRBS1; 1.
DR   Gene3D; 3.30.1370.10; K Homology domain, type 1; 1.
DR   InterPro; IPR045071; BBP-like.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR032571; Qua1_dom.
DR   InterPro; IPR032335; Sam68-YY.
DR   PANTHER; PTHR11208:SF30; KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 1; 1.
DR   PANTHER; PTHR11208; RNA-BINDING PROTEIN RELATED; 1.
DR   Pfam; PF00013; KH_1; 1.
DR   Pfam; PF16274; Qua1; 1.
DR   Pfam; PF16568; Sam68-YY; 1.
DR   SMART; SM00322; KH; 1.
DR   SUPFAM; SSF54791; Eukaryotic type KH-domain (KH-domain type I); 1.
DR   PROSITE; PS50084; KH_TYPE_1; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell cycle; Cytoplasm; Isopeptide bond; Membrane; Methylation;
KW   mRNA processing; Nucleus; Phosphoprotein; Reference proteome; RNA-binding;
KW   SH3-binding; Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..443
FT                   /note="KH domain-containing, RNA-binding, signal
FT                   transduction-associated protein 1"
FT                   /id="PRO_0000050126"
FT   DOMAIN          171..197
FT                   /note="KH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REGION          1..95
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          100..260
FT                   /note="Involved in homodimerization"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   REGION          280..317
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          326..345
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          351..443
FT                   /note="Interaction with HNRNPA1"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   REGION          400..420
FT                   /note="Interaction with ZBTB7A"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   REGION          411..443
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60749"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         33
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         45
FT                   /note="Asymmetric dimethylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         52
FT                   /note="Asymmetric dimethylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60749"
FT   MOD_RES         84
FT                   /note="Phosphothreonine; by MAPK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q60749"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60749"
FT   MOD_RES         150
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         175
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         183
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         282
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         284
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         291
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60749"
FT   MOD_RES         304
FT                   /note="Asymmetric dimethylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         310
FT                   /note="Omega-N-methylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         315
FT                   /note="Omega-N-methylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         320
FT                   /note="Dimethylated arginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         320
FT                   /note="Omega-N-methylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         325
FT                   /note="Omega-N-methylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         331
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q60749"
FT   MOD_RES         331
FT                   /note="Dimethylated arginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         331
FT                   /note="Omega-N-methylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         340
FT                   /note="Dimethylated arginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         340
FT                   /note="Omega-N-methylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         387
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         390
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         435
FT                   /note="Phosphotyrosine; by PTK6"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         440
FT                   /note="Phosphotyrosine; by PTK6"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   MOD_RES         443
FT                   /note="Phosphotyrosine; by PTK6"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   CROSSLNK        96
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   CROSSLNK        102
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   CROSSLNK        139
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   CROSSLNK        175
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
FT   CROSSLNK        432
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q07666"
SQ   SEQUENCE   443 AA;  48315 MW;  C41A42831E7DCBC7 CRC64;
     MQRRDDPAAR LTRSSGRSCS KDPSGAHPSV RLTPSRPSPL PHRSRGGGGG PRGGARASPA
     TQPPPLLPPS NPGPDATVVG SAPTPLLPPS ATAAAKMEPE NKYLPELMAE KDSLDPSFTH
     AMQLLSVEIE KIQKGESKKD DEENYLDLFS HKNMKLKERV LIPVKQYPKF NFVGKILGPQ
     GNTIKRLQEE TGAKISVLGK GSMRDKAKEE ELRKGGDPKY AHLNMDLHVF IEVFGPPCEA
     YALMAHAMEE VKKFLVPDMM DDICQEQFLE LSYLNGVPEP SRGRGVSVRG RGAAPPPPPV
     PRGRGVGPPR GALVRGTPVR GSITRGATVT RGVPPPPTVR GAPTPRARTA GIQRIPLPPT
     PAPETYEDYG YDDSYAEQSY EGYEGYYSQS QGESEYYDYG HGELQDSYEA YGQDDWNGTR
     PSLKAPPARP VKGAYREHPY GRY
//
